MEDI7734
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI7734, covering 2024-12-13 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]